.jpg)
Alzheimer’s Disease: A Long Journey and Another Step Forward
According to a recent article in MedicalXpress, the newest discovery in the search to reduce the risk of AD was through the work of researchers led by Dr. Jaehong Suh,…
<a href="https://pixabay.com/users/DarkoStojanovic/">DarkoStojanovic</a> / Pixabay
Experimental Spinocerebellar Ataxia Treatment Earns Orphan Drug Designation
According to a story from Bloomberg, the company Cadent Therapeutics recently announced that the company's experimental product candidate CAD-1883 has earned Orphan Drug Designation from the US Food and Drug…
<a href="https://pixabay.com/users/PublicDomainPictures/">PublicDomainPictures</a> / Pixabay
Experimental Treatment for Spinocerebellar Ataxia Earns Orphan Drug Designation from the FDA
According to a story from Business Wire, the drug developer Cadent Therapeutics recently announced that its investigational drug CAD-1883 has been awarded Orphan Drug Designation from the US Food and…
<a href="https://pixabay.com/users/jarmoluk/">jarmoluk</a> / Pixabay
Experimental Treatment for Spinocerebellar Ataxia Earns Orphan Drug Designation
According to a story from BioSpace, the drug developer Cadent Therapeutics recently announced that its investigational product candidate CAD-1883 has earned Orphan Drug Designation from the US Food and Drug…
<a href="https://pixabay.com/users/cocoparisienne/">cocoparisienne</a> / Pixabay
This Spinocerebellar Ataxia Patient is Committed to Spreading Awareness
According to a story from Kamloops Coffee Talk, Darrin Rein, of Kamloops, British Columbia, was just recently diagnosed with spinocerebellar ataxia, a rare disease that affects mobility and coordination. Despite…
Exciting Gene Therapy Progress in Huntington’s Disease and Spinocerebellar Ataxia
Huntington's Disease & SCAs Huntington's disease (HD) and spinocerebellar ataxia (SCA) are both neurodegenerative diseases caused by the same type of error in the body's DNA. Essentially, the CAG or…
source: pixabay.com
First Patient Enrolled in Spinocerebellar Ataxia Clinical Trial
According to a story from Market Screener, the biopharmaceutical company Biohaven Pharmaceutical Holding Company Ltd. recently announced that the first patient has been enrolled in the company's Phase 3 clinical…
<a href="https://pixabay.com/users/WikimediaImages/">WikimediaImages</a> / Pixabay
Phase 2 Friedreich’s Ataxia Trial Given Green Light in Spain
According to a story from BioSpace, the biotechnology company Minoryx Therapeutics recently announced that the company has received official approval from the Spanish Agency of Medicines and Medical Devices (AEMPS)…
30 Million Euros Allocated to Fund Precision Medicine Research Projects for Neurodegenerative Diseases
Precision mNedicine is the latest craze in rare disease research. Thankfully for patients, it is completely, 100% centered on improving the quality of their care. Unlike most typical healthcare practices,…
Source: Pixabay.com
New Orphan Drug Designation for Potential Spinocerebellar Ataxia Treatment
Spinocerebellar Ataxia (SCA) refers to a group of neurodegenerative disorders. Ataxias are a component of the nervous system which control movement. SCA occurs when the ataxias in the brain or spinal…
<a href="https://pixabay.com/users/mattthewafflecat/">mattthewafflecat</a> / Pixabay
Researchers Identify a Protein Linked to Ataxia and ALS
A recent study carried out by scientists from the University of Utah Health has highlighted the role of a protein called Staufen1 in spinocerebellar ataxia type 2 and amyotrophic lateral…
Electrical Brain Stimulation Could Effectively Treat Neurodegenerative Ataxias
According to Newswise, new findings indicate that electrical stimulation of the spinal cord and brain may be effective in treating symptoms of a group of rare neurological movement disorders, neurodegenerative ataxias.…
Source: Pixabay.com
FDA Gives Greenlight to Test New Treatment for Spinocerebellar Ataxia
According to a story from Beyond the Dish, a new experimental treatment for spinocerebellar ataxia was given the go-ahead from the U.S. Food and Drug Administration for testing. The investigational…
Source: Pixabay
Research into SCA Reveals Processes Behind Development
Researchers at Northwestern University (NU) have published research showing that changes in the brain causing spinocerebellar ataxia type 1 (SCA1) occur at a younger age than previously thought, reports NeuroscienceNews.…
source: pixabay.com
Clinical Trials Begin for a Possible Spinocerebellar Ataxia Treatment
According to a story from pharmavoice.com, the pharmaceutical company Cadent Therapeutics has announced the beginning of the Phase I clinical study for its drug candidate CAD-1883. The therapy is a…
<a href="https://pixabay.com/users/geralt/">geralt</a> / Pixabay
What Will Biohaven Learn from SCA Drug’s Failed Clinical Trial?
A much-lauded piece of wisdom in engineering is that “failures teach more than successes.” While this might seem to contradict itself, I ask you to think back to your own…
Source: https://pixabay.com/en/statistics-transparency-company-1445484/
First-in-Class Drug May be Coming to You, SCA Patients!
Biohaven Pharmaceutical Holding Company Ltd. announced at the end of last month that the company has completed enrollment in its Phase 3 clinical trial of trigriluzole in spinocerebellar ataxia (SCA)…
